title: CUSP/p63 expression in rat and human tissues.
abstract: The human homolog of KET, p63, bears strong homology to the tumor suppressor p53 and plays an essential role in epithelial development. CUSP, the most abundant cutaneous product of p63, has been identified as an autoantigen in chronic ulcerative stomatitis (CUS). The original report of KET expression at least partially contradicts p63 expression subsequently reported by many different groups. We have examined p63 expression by Northern analysis of RNA from multiple human tissues and by indirect immunofluorescence of rat tissue with CUS patient sera. Northern analysis reveals p63 RNA in skin, thymus, placenta, skeletal muscle, kidney, and lung, with non-transactivating p63 RNA in skin, thymus, and placenta. Reverse transcriptase polymerase chain reaction (rtPCR) assays show abundant non-transactivating p63 RNA, and little to no transactivating p63 RNA, in human basal cell carcinoma as well as in normal skin adjacent to the tumors. p63 RNA expression was not detected in brain, heart, colon, spleen, liver, or small intestine. Immunofluorescence reveals p63 expression in skin, oral epithelium, tongue, kidney, and trachea, but not in liver, large intestine, testis, skeletal muscle, or heart. Focal p63 expression within tissues, the complex array of isoforms encoded by the gene, and the specificity of the probes and antibodies utilized, may all contribute to contradictory accounts of CUSP/p63 expression.
authors.affiliation: Department of Dermatology, University of Colorado School of Medicine, B-153, 4200 E. Ninth Avenue, Denver, CO 90262, USA.
authors.forename: R P
authors.initials: RP
authors.lastname: Dellavalle
authors.forename: T B
authors.initials: TB
authors.lastname: Egbert
authors.forename: A
authors.initials: A
authors.lastname: Marchbank
authors.forename: L J
authors.initials: LJ
authors.lastname: Su
authors.forename: L A
authors.initials: LA
authors.lastname: Lee
authors.forename: P
authors.initials: P
authors.lastname: Walsh
mesh_terms: D000818:Animals; D004268:DNA-Binding Proteins; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D016147:Genes, Tumor Suppressor; D014644:Genetic Variation; D005892:Gingivitis, Necrotizing Ulcerative / Q000235:genetics*; D006801:Humans; D007668:Kidney / Q000378:metabolism; D008297:Male; D008565:Membrane Proteins; D009061:Mouth Mucosa / Q000378:metabolism; D009928:Organ Specificity; D010750:Phosphoproteins / Q000032:analysis / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D012867:Skin / Q000378:metabolism; D014059:Tongue / Q000378:metabolism; D014132:Trachea / Q000378:metabolism; D015534:Trans-Activators / Q000032:analysis / Q000235:genetics*; D014157:Transcription Factors; D014158:Transcription, Genetic; D016159:Tumor Suppressor Protein p53; D025521:Tumor Suppressor Proteins
chemical_list: C081876:CKAP4 protein, human; D004268:DNA-Binding Proteins; D008565:Membrane Proteins; D010750:Phosphoproteins; D012333:RNA, Messenger; C115051:TP63 protein, human; C108581:Tp63 protein, rat; D015534:Trans-Activators; D014157:Transcription Factors; D016159:Tumor Suppressor Protein p53; D025521:Tumor Suppressor Proteins